Diabetes Care: In addition to blood sugar and glycation, this indicator of diabetes patients is also closely related to the risk of cardiovascular disease!

The resting heart rate is the number of heartbeats per minute when you are awake and quiet.

medsci.

And non- diabetic patients compared to patients with diabetes resting heart rate (the RHR) high, and non- diabetic patients compared to patients with diabetes resting heart rate (the RHR) high, diabetes

The Diabetes Control and Complications Trial (DCCT) has reported that intensive treatment can significantly reduce compared with traditional diabetes treatment, with an average reduction of 1.

The Diabetes Control and Complications Trial (DCCT) has reported that intensive treatment can significantly reduce compared with traditional diabetes treatment, with an average reduction of 1.

The higher mean pulse measured in the annual physical examination for type 1 diabetes is an independent and significant predictor of any CVD and major adverse cardiovascular events (MACE).

In order to evaluate how long the beneficial effects of previous intensive treatments on RHR will last, and what factors regulate the differences observed between the two former DCCT treatment groups during EDIC, recently, led by the University of Barcelona, ​​International DEET/EDIC The research assistance jointly conducted an additional 12 years of research.

The study aims to evaluate whether the beneficial effects of intensive treatment and conventional diabetes treatment on heart rate continue, so as to find factors that mediate the difference in heart rate between treatment groups and the effect of heart rate on future CVD risks.

Average heart rate of DCCT treatment group during EDIC during conventional treatment (dotted line) and intensive treatment (solid line)

Average heart rate of DCCT treatment group during EDIC during conventional treatment (dotted line) and intensive treatment (solid line)

In this study, a total of 1402 patients with type 1 diabetes were evaluated for longitudinal changes in their heart rates.

The results showed that at the end of DCCT, the participants had an average duration of diabetes of 12 ± 5 years.

Through EDIC, participants in the intensive group had a significantly lower heart rate compared with the conventional group.

Cox model of any CVD and MACE during DCCT/EDIC

Cox model of any CVD and MACE during DCCT/EDIC

It can be seen that after 22 years of follow-up, the previous intensive treatment is still significantly associated with a lower heart rate compared with conventional treatment, which is consistent with the long-term beneficial effect of intensive treatment on cardiovascular disease.

It can be seen that after 22 years of follow-up, the previous intensive treatment is still significantly associated with a lower heart rate compared with conventional treatment, which is consistent with the long-term beneficial effect of intensive treatment on cardiovascular disease.

references:

diabetesjournals.

diabetesjournals.
org/content/44/5/1125.
figures-only" target="_blank" rel="noopener">Factors for Longitudinal Resting Heart Risk Rate and Its Associations With at The Cardiovascular Outcomes in the DCCT / EDIC Study.
org/10.
2337/dc20-2387" target="_blank" rel="noopener">Https://doi.
org/10.
2337/dc20-2387

in this message